Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17027579 | 0.94 | LMNA (0.34) | LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL17036604 | 0.92 | ALDH1A1 (0.37) | LMNAALDH1A1SMN1; SMN2PGRADRA2A | |
| SCHEMBL18815541 | 0.89 | KMT2A (0.36) | LMNAALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL17027554 | 0.89 | KMT2A (0.34) | LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL19996620 | 0.84 | — | — | |
| SCHEMBL18815535 | 0.84 | PPARG (0.35) | LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL14227660 | 0.82 | HSP90AA1 (0.34) | LMNAALDH1A1NPSR1SMN1; SMN2PGR | |
| SCHEMBL18255354 | 0.82 | PGR (0.33) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL18817800 | 0.80 | KDM4E (0.32) | — | |
| SCHEMBL16863840 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9926258-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2018-03-27 | — | — | US | disclosed |
| US-20160347704-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20160347704-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2016-12-01 | — | — | US | disclosed |
| WO-2015124671-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160347704-A1 | PHOTOLABILE PRO-FRAGRANCES | CUTA, FAAH, FAAH2 | LMNA 387/4885ALDH1A1 94/4885NPSR1 1854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.